Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Tatva Chintan Pharma Chem Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 125 | 114 | 97 | 84 | 98 | 105 | 83 | 86 | 108 | 117 | 124 | 131 | 134 |
| Expenses + | 108 | 93 | 76 | 73 | 83 | 93 | 78 | 79 | 99 | 100 | 101 | 106 | 106 |
| Operating Profit | 16 | 21 | 20 | 11 | 16 | 13 | 6 | 7 | 9 | 17 | 22 | 25 | 28 |
| OPM % | 13% | 19% | 21% | 13% | 16% | 12% | 7% | 8% | 8% | 15% | 18% | 19% | 21% |
| Other Income + | -3 | 1 | 1 | 1 | 5 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | -0 |
| Interest | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Depreciation | 3 | 6 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 10 |
| Profit before tax | 8 | 13 | 11 | 5 | 14 | 7 | -1 | -0 | 2 | 9 | 14 | 18 | 17 |
| Tax % | -117% | 29% | 31% | 34% | 30% | 24% | -34% | -165% | 49% | 27% | 27% | 14% | 38% |
| Net Profit + | 17 | 10 | 8 | 3 | 10 | 5 | -1 | 0 | 1 | 7 | 10 | 15 | 10 |
| EPS in Rs | 7.65 | 4.29 | 3.33 | 1.48 | 4.11 | 2.23 | -0.28 | 0.06 | 0.44 | 2.84 | 4.24 | 6.49 | 4.41 |
Financials of Tatva Chintan Pharma Chem Ltd
Annual income statement trend
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 136 | 206 | 263 | 300 | 434 | 424 | 394 | 383 | 506 |
| Expenses + | 113 | 172 | 208 | 234 | 325 | 363 | 325 | 348 | 413 |
| Operating Profit | 23 | 34 | 55 | 67 | 109 | 61 | 69 | 35 | 93 |
| OPM % | 17% | 17% | 21% | 22% | 25% | 14% | 17% | 9% | 18% |
| Other Income + | 1 | 1 | 1 | 5 | 9 | 2 | 7 | 2 | 4 |
| Interest | 3 | 4 | 4 | 4 | 5 | 9 | 7 | 2 | 3 |
| Depreciation | 3 | 4 | 5 | 7 | 8 | 10 | 26 | 28 | 37 |
| Profit before tax | 19 | 27 | 48 | 61 | 104 | 45 | 44 | 8 | 57 |
| Tax % | 35% | 25% | 21% | 14% | 8% | -2% | 30% | 25% | 26% |
| Net Profit + | 12 | 21 | 38 | 52 | 96 | 45 | 30 | 6 | 42 |
| EPS in Rs | 15.30 | 25.56 | 47.03 | 26.02 | 43.25 | 20.52 | 12.97 | 2.44 | 17.98 |
| Dividend Payout % | 0% | 0% | 0% | 19% | 5% | 10% | 15% | 41% | 0% |
Financials of Tatva Chintan Pharma Chem Ltd
Capital structure and asset base
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 20 | 22 | 22 | 23 | 23 | 23 |
| Reserves | 51 | 72 | 110 | 146 | 451 | 493 | 714 | 715 | 758 |
| Borrowings + | 56 | 77 | 91 | 90 | 120 | 170 | 14 | 36 | 120 |
| Other Liabilities + | 28 | 31 | 41 | 59 | 65 | 74 | 67 | 61 | 102 |
| Total Liabilities | 144 | 188 | 249 | 315 | 658 | 759 | 819 | 836 | 1,004 |
| Fixed Assets + | 57 | 67 | 111 | 120 | 160 | 196 | 427 | 526 | 611 |
| CWIP | 10 | 6 | 5 | 10 | 51 | 231 | 77 | 27 | 23 |
| Investments | 1 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 4 |
| Other Assets + | 76 | 115 | 133 | 185 | 447 | 332 | 305 | 283 | 365 |
| Total Assets | 144 | 188 | 249 | 315 | 658 | 759 | 819 | 836 | 1,004 |
Financials of Tatva Chintan Pharma Chem Ltd
Operating, investing and financing cash movement
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 13 | 7 | 25 | 20 | 20 | 28 | 98 | 25 | 31 |
| Cash from Investing Activity + | -30 | -17 | -40 | -21 | -197 | -101 | -121 | -65 | -116 |
| Cash from Financing Activity + | 7 | 17 | 10 | -5 | 235 | 38 | 31 | 17 | 79 |
| Net Cash Flow | -10 | 8 | -5 | -6 | 59 | -36 | 8 | -24 | -5 |
| Free Cash Flow | -18 | -2 | -23 | -1 | -69 | -175 | -30 | -51 | -82 |
| CFO/OP | 105% | 39% | 61% | 44% | 36% | 61% | 157% | 84% | 42% |
Financials of Tatva Chintan Pharma Chem Ltd
Working capital efficiency and return ratios
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77 | 73 | 69 | 110 | 48 | 73 | 65 | 79 | 86 |
| Inventory Days | 148 | 114 | 175 | 173 | 319 | 262 | 320 | 246 | 319 |
| Days Payable | 127 | 71 | 87 | 114 | 83 | 52 | 94 | 60 | 95 |
| Cash Conversion Cycle | 99 | 116 | 157 | 169 | 283 | 283 | 291 | 264 | 310 |
| Working Capital Days | 15 | 46 | 47 | 74 | 74 | 25 | 158 | 148 | 92 |
| ROCE % | 22% | 28% | 28% | 26% | 9% | 7% | 1% | 7% |